| Rapid and Accurate |
In today's dynamic diagnostic market, technological innovation and rapid response are vital. Our cutting-edge real-time PCR and NGS-based solutions deliver fast and precise infectious disease diagnostics, enabling timely clinical decisions and more effective healthcare responses.
| Next-Generation |
Innovation in diagnostic technology is crucial for global competitiveness. We are dedicated to advance NGS-based diagnostics optimized for infectious disease detection, genome analysis, and mutation monitoring. These efforts drive progress in personalized medicine, pathogen response, and antibiotic resistance tracking, setting new benchmarks in healthcare solutions.
| Commercialization and |
Beyond developing advanced technologies, we focus on commercializing diagnostic solutions that comply with domestic and international regulatory standards. This approach strengthens our competitive presence and drives our growth in the global market.
| Contribution
to Public |
Our diagnostic technologies go beyond commercial success—they play a vital role in enhancing public health. By enabling early detection of infectious diseases, our solutions help curb their spread, particularly in resource-limited regions. This commitment improves diagnostic access and supports timely treatment for vulnerable populations worldwide.
 |
Real-Time PCR |
Enables the rapid and accurate detection of pathogens, such as viruses and bacteria, ensuring precise diagnosis of infectious disease. |
 |
NGS |
Enables comprehensive genomic analysis for infectious and chronic diseases as well as genetic disorder, providing detailed insights into patient-specific treatment strategies. This technology allows precise and personalized diagnostics based on bioinformatics analysis. |
 |
POCT |
Facilitates rapid and accurate diagnostics at the point of care, supporting public health efforts through timely treatment decisions. |
